Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling.

Atrih A, Mudaliar MA, Zakikhani P, Lamont DJ, Huang JT, Bray SE, Barton G, Fleming S, Nabi G.

Br J Cancer. 2014 Mar 18;110(6):1622-33. doi: 10.1038/bjc.2014.24. Epub 2014 Feb 18.

2.

Pathway analysis of kidney cancer using proteomics and metabolic profiling.

Perroud B, Lee J, Valkova N, Dhirapong A, Lin PY, Fiehn O, Kültz D, Weiss RH.

Mol Cancer. 2006 Nov 24;5:64.

3.

Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.

Sandim V, Pereira Dde A, Kalume DE, Oliveira-Carvalho AL, Ornellas AA, Soares MR, Alves G, Zingali RB.

Urol Oncol. 2016 Jan;34(1):5.e11-25. doi: 10.1016/j.urolonc.2015.07.016. Epub 2015 Sep 26.

PMID:
26420021
4.

Comparative membrane proteomics: a technical advancement in the search of renal cell carcinoma biomarkers.

Raimondo F, Corbetta S, Savoia A, Chinello C, Cazzaniga M, Rocco F, Bosari S, Grasso M, Bovo G, Magni F, Pitto M.

Mol Biosyst. 2015 Jun;11(6):1708-16. doi: 10.1039/c5mb00020c.

5.

Label-free quantitative proteomic analysis reveals potential biomarkers and pathways in renal cell carcinoma.

Zhao Z, Wu F, Ding S, Sun L, Liu Z, Ding K, Lu J.

Tumour Biol. 2015 Feb;36(2):939-51. doi: 10.1007/s13277-014-2694-2. Epub 2014 Oct 15.

PMID:
25315187
6.

Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma.

Giribaldi G, Barbero G, Mandili G, Daniele L, Khadjavi A, Notarpietro A, Ulliers D, Prato M, Minero VG, Battaglia A, Allasia M, Bosio A, Sapino A, Gontero P, Frea B, Fontana D, Destefanis P.

J Proteomics. 2013 Oct 8;91:385-92. doi: 10.1016/j.jprot.2013.07.018. Epub 2013 Jul 31.

7.

Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma.

White NM, Masui O, Desouza LV, Krakovska O, Metias S, Romaschin AD, Honey RJ, Stewart R, Pace K, Lee J, Jewett MA, Bjarnason GA, Siu KW, Yousef GM.

Oncotarget. 2014 Jan 30;5(2):506-18.

8.

Comparative proteomic profiling identifies potential prognostic factors for human clear cell renal cell carcinoma.

Sun X, Zhang H, Luo L, Zhong K, Ma Y, Fan L, Fu D, Wan L.

Oncol Rep. 2016 Dec;36(6):3131-3138. doi: 10.3892/or.2016.5159. Epub 2016 Oct 11.

9.

Use of quantitative shotgun proteomics to identify fibronectin 1 as a potential plasma biomarker for clear cell carcinoma of the kidney.

Yokomizo A, Takakura M, Kanai Y, Sakuma T, Matsubara J, Honda K, Naito S, Yamada T, Ono M.

Cancer Biomark. 2011-2012;10(3-4):175-83. doi: 10.3233/CBM-2012-0243.

PMID:
22674303
10.

iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma.

Zhang L, Jiang H, Xu G, Chu N, Xu N, Wen H, Gu B, Liu J, Mao S, Na R, Jing Y, Ding Q, Zhang Y, Wang L.

Biosci Trends. 2016 Jul 19;10(3):210-9. doi: 10.5582/bst.2016.01055. Epub 2016 Jun 17.

11.

Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance.

Masui O, White NM, DeSouza LV, Krakovska O, Matta A, Metias S, Khalil B, Romaschin AD, Honey RJ, Stewart R, Pace K, Bjarnason GA, Siu KW, Yousef GM.

Mol Cell Proteomics. 2013 Jan;12(1):132-44. doi: 10.1074/mcp.M112.020701. Epub 2012 Oct 17.

12.

Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.

Siu KW, DeSouza LV, Scorilas A, Romaschin AD, Honey RJ, Stewart R, Pace K, Youssef Y, Chow TF, Yousef GM.

J Proteome Res. 2009 Aug;8(8):3797-807. doi: 10.1021/pr800389e.

PMID:
19610612
13.

Metabolomic study of human tissue and urine in clear cell renal carcinoma by LC-HRMS and PLS-DA.

Nizioł J, Bonifay V, Ossoliński K, Ossoliński T, Ossolińska A, Sunner J, Beech I, Arendowski A, Ruman T.

Anal Bioanal Chem. 2018 Jun;410(16):3859-3869. doi: 10.1007/s00216-018-1059-x. Epub 2018 Apr 16.

14.

Stage-related alterations in renal cell carcinoma--comprehensive quantitative analysis by 2D-DIGE and protein network analysis.

Junker H, Venz S, Zimmermann U, Thiele A, Scharf C, Walther R.

PLoS One. 2011;6(7):e21867. doi: 10.1371/journal.pone.0021867. Epub 2011 Jul 7.

15.

Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples.

Raimondo F, Morosi L, Chinello C, Perego R, Bianchi C, Albo G, Ferrero S, Rocco F, Magni F, Pitto M.

Mol Biosyst. 2012 Apr;8(4):1007-16. doi: 10.1039/c2mb05372a. Epub 2011 Dec 13.

PMID:
22159573
16.

Imaging the clear cell renal cell carcinoma proteome.

Morgan TM, Seeley EH, Fadare O, Caprioli RM, Clark PE.

J Urol. 2013 Mar;189(3):1097-103. doi: 10.1016/j.juro.2012.09.074. Epub 2012 Sep 23.

17.

Differencial proteome of clear-cell renal cell carcinoma (ccRCC) tissues.

Vieira de Ribeiro AJ, Sandim V, Ornellas AA, Reis RS, Domont G, Alves G.

Int Braz J Urol. 2013 Jan-Feb;39(1):83-94. doi: 10.1590/S1677-5538.IBJU.2013.01.11.

18.

PGRMC1 Is a Novel Potential Tumor Biomarker of Human Renal Cell Carcinoma Based on Quantitative Proteomic and Integrative Biological Assessments.

Zhang D, Xia X, Wang X, Zhang P, Lu W, Yu Y, Deng S, Yang H, Zhu H, Xu N, Liang S.

PLoS One. 2017 Jan 20;12(1):e0170453. doi: 10.1371/journal.pone.0170453. eCollection 2017.

19.

Proteomic analysis of formalin-fixed paraffin-embedded renal tissue samples by label-free MS: assessment of overall technical variability and the impact of block age.

Craven RA, Cairns DA, Zougman A, Harnden P, Selby PJ, Banks RE.

Proteomics Clin Appl. 2013 Apr;7(3-4):273-82. doi: 10.1002/prca.201200065. Epub 2013 Mar 6.

20.

Urine screening by Seldi-Tof, followed by biomarker identification, in a Brazilian cohort of patients with renal cell carcinoma (RCC).

Alves G, Pereira DA, Sandim V, Ornellas AA, Escher N, Melle C, von Eggeling F.

Int Braz J Urol. 2013 Mar-Apr;39(2):228-39. doi: 10.1590/S1677-5538.IBJU.2013.02.12.

Supplemental Content

Support Center